-
Mashup Score: 8Izarhea | Leukemia and Lymphoma Society - 2 month(s) ago
First of all, I want to thank God for keeping me sane as he forced me to grow this year. On June 25, 2023, I was diagnosed with Hodgkin lymphoma (HL), and to be honest, I wasn’t tripping at first because I had no idea what that meant. Then my mom explained to me that I had cancer. I went from ending my junior year to celebrating my 17th birthday to getting my port installed and starting chemo all in the same month. I remember telling my dad how scared I was for my whole life to change, but I eventually saw how necessary that was. My whole life I had based my personality on my hair. I was always trying new styles and playing with my hair. I always felt that was everyone’s favorite thing about me, so saying goodbye to my first clump in July really sucked. Every two weeks for the past six months, I’ve been getting chemo and a number of other meds pumped into my bloodstream for hours and hours and hours. As of yesterday, I can proudly say that I will never have to do that again. I’m gratef
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 33Novel CD7 CAR T-cells for refractory T-cell malignancies affecting pediatric and AYA patients | Leukemia and Lymphoma Society - 2 month(s) ago
T-cell leukemias and lymphomas have devastating outcomes if they recur after or don’t respond to standard treatment, with the only hope of cure being bone marrow transplant (BMT). Unfortunately, many pediatric, adolescent and young adult (AYA) patients are unable to achieve clinical remission (and thus unable to proceed to BMT) with standard salvage therapies, which are often even more toxic than upfront therapies. Available treatment options for patients with relapsed or refractory T-cell malignancies (particularly pediatric and AYA patients) are lacking, thus 3-year survival rates are
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
On this #WorldCancerResearchDay, we’re proud to spotlight our grant to Dr. Rayne Rouce, whose groundbreaking work is transforming the future of treatment for young patients with T-cell #BloodCancer. 🧬 Get all the details 👉 https://t.co/DKhm7YmvUD https://t.co/YTIfPZymuk
-
-
Mashup Score: 0Information Specialists | Leukemia and Lymphoma Society - 2 month(s) ago
Information Specialists > Page Components
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
Do you or a loved one have questions about blood cancer? Connect with oncology social workers and nurses for free support and resources 👉 https://t.co/u60TmlFhYy
-
-
Mashup Score: 5Information Specialists | Leukemia and Lymphoma Society - 2 month(s) ago
Information Specialists > Page Components
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
Are you or a loved one in need of free support, resources or information about blood cancer? ❤️ Get in touch with us 👉 https://t.co/h7aiaRHg3w
-
-
Mashup Score: 0
Doctors classify acute lymphoblastic leukemia (ALL) into subtypes by using various tests. It’s important to get an accurate diagnosis since your subtype plays a large part in deciding the type of treatment you’ll receive. Depending on your ALL subtype, the doctor will determine The type of drug combination needed for your treatment The length of time you’ll need to be in treatment Other types of treatment that may be needed to achieve the best outcomes. Leukemia cells can be classified by the unique set
Source: www.lls.orgCategories: General Medicine News, PayerTweet-
Why are subtypes important in acute lymphoblastic leukemia (ALL)? Today’s treatment options include targeted therapies based on subtype. 🔗Learn more: https://t.co/okUxEtxVq4 #WorldALLDay https://t.co/LoVD8bF2ny
-
-
Mashup Score: 1Patient Support | Leukemia and Lymphoma Society - 2 month(s) ago
Patient Support > Page Components
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
We have free resources and information on all blood cancers. Get in touch now 👉 https://t.co/pEsJ1BhFgG (3/3) https://t.co/wO8huYeVLG
-
-
Mashup Score: 2Patient Support | Leukemia and Lymphoma Society - 2 month(s) ago
Patient Support > Page Components
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
We all experience grief differently. Birthdays, holidays and special occasions can be extra challenging for those missing loved ones. Please know, we're here to offer support to all those affected by blood cancer with resources on grief and loss 👉 https://t.co/VTqce6ugPI (3/3) https://t.co/UJQ8UcQWUr
-
-
Mashup Score: 3Information Specialists | Leukemia and Lymphoma Society - 2 month(s) ago
Information Specialists > Page Components
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
Speak with knowledgeable oncology social workers and nurses who truly understand blood cancer. We are here for you 👉 https://t.co/IPUzKcnPyR
-
-
Mashup Score: 2Patient Support | Leukemia and Lymphoma Society - 2 month(s) ago
Patient Support > Page Components
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
We have free resources and information on all blood cancers. Get in touch now 👉 https://t.co/Ggx17OXysN
-
-
Mashup Score: 1Information Specialists | Leukemia and Lymphoma Society - 2 month(s) ago
Information Specialists > Page Components
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
Speak directly with oncology social workers and nurses about your blood cancer questions—no automated systems, just compassionate support. Call us today 👉 https://t.co/6qxQ9uay59
-
“I went from ending my junior year to celebrating my 17th birthday to getting my port installed and starting chemo all in the same month.” - Izarhea, student, Adolescent and Young Adult (AYA), and lymphoma survivor. Read her #BloodCancer story 👉 https://t.co/zvesvU3Vt8 (1/3) https://t.co/Q9EFpmrge2